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Endom etriosis is a com m on gynaecological disease associated w ith pelvic pain 
and infertility. C urrent treatm ents include oral contraceptives com bined with non­
steroidal anti inflam m atory drugs or surgery to  rem ove lesions, all o f  w hich provide a  
tem porary but no t com plete cure. H ere w e identify an  endom etriosis-targeting peptide 
that is internalized by cells, designated z l3 ,  using phage display. A s m ost endom etri­
osis occurs on organ surfaces facing the peritoneum , we subtracted a phage display 
library w ith  fem ale m ouse peritoneum  tissue and selected phage clones by binding to 
hum an endom etrial epithelial cells. P roteom ics analysis revealed the z l3  receptor as 
the cyclic nucleotide-gated channel (13, a sorting pathway protein. We then linked z l3  
w ith an  apoptosis inducing peptide and with an endosom e -escaping peptide. W hen 
these peptides were co- adm inistered into the peritoneum  o f  baboons w ith  endom etri­
osis, cells in lesions selectively underw ent apoptosis with no effect on neighbouring 
organs. Thus, this study presents a strategy that could be useful to treat peritoneal e n ­
dom etriosis in humans. Endom etriosis occurs only in higher prim ates, including h u ­
m ans and baboons. Spontaneous endom etriosis reportedly occurs in about 25 %  o f  
captive baboons, and its prevalence increases with captivity duration [5]. Experi­
m ents in non -human prim ates show a clear positive correlation betw een endom etrio­
sis and a diet containing the chem ical dioxin  [6, 7], w hich m ay prom ote endom etrio­
sis by acting as an  estrogen  like factor, h i patients w ith  endom etriosis, m any o f  the 
pathologic processes including inflam m ation, the im m une response, angiogenesis and 
apoptosis are all favoured for prom oting endom etriosis in a m anner dependent on 
steroid horm ones -  |X, 9|. Thus, in  the past, m ost treatm ent was v ia  therapeutics­
targeting steroid horm ones and  their receptors [10, 11 j. T hese drags can only be 
adm inistered for a  short term  due to side effects. Current first-line therapy is oral con­
traceptive pills, w hich halt an ovulation and suppress endom etriosis tissue growth 
with m inim um  side effect [ 12 j. Oral contraceptive pills are also adm inistered w ith 
nonsteroidal anti-inflam m atoiy drags, further reducing endom etriosis-associated pain 
113, 14]. N onetheless, these treatm ents do not rem ove endom etriosis, and patients 
with severe sym ptom s m ust undergo surgery. H ow ever, even then sym ptom s can r e ­
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cur, requiring m ultiple surgeries in m any cases [15]. Thus, it is critical to develop 
new  strategies to cure this disease, particularly to prevent recurrence after surgery.
One proposed cause for endom etriosis is through retrograde m enstrual reflux o f  
the endom etrium  that becom es im planted in regions o f  the pelvis [16], m ost com m on­
ly on  the ovaries and areas facing the peritoneum  [17, 18]. Thus, we hypothesized 
that a m olecule specifically expressed on the endom etrial surface could be targeted 
by a  peritoneally injected drug if  that m arker is not expressed by other peritoneal su r­
faces. W e report here the identification o f  such a reagent, nam ely, a 9-m er peptide 
that specifically binds to glandular epithelial cells o f  endom etriosis in  peritoneum. 
W e also identified its receptor as the cyclic nucleotide-gated channel [)39(CNGB3) 
and confirm ed its expression in  endom etriosis. O n  the basis o f  these findings, w e de­
veloped potential therapeutics for endom etriosis targeting disease lesions at peritone­
al surfaces mid tested their activity in baboon endom etriosis m odels. This study p re­
sents a strategy that could be useful to treat peritoneal endom etriosis in humans.
Identification o f  peptides targeting peritoneal endom etriosis,
As yet, there is neither an  in vitro m odel nor an  in vivo animal model available 
to study endom etriosis, other than non-hum an prim ates. To identify a peptide that 
specifically binds to epithelial cells in endom etriosis, we hypothesized that som e, if 
not all, hum an endom etrial adenocarcinom a cell lines w ould express cell surface pro­
teins expressed in glandular epithelial cells in endom etriosis. To devise a probe that 
specifically binds to the endom etriosis surface but no t to the surface o f  other organs 
facing the peritoneum , w e undertook subtractive phage library.' screening [ 18, 19|. A  
T7 phage-based library (109clones, 101 ‘plaque-form ing unit) o f  linear 9-m er peptides 
w as injected into tire peritoneal cavity o f  a  fem ale m ouse to allow  absorption o f 
phage clones to the peritoneal surface in vivo for 1 h. The precleared libraiy w as re ­
covered from  peritoneal fluid and added to a m onolayer o f  hum an endom etrial ad e­
nocarcinom a Ishikaw a cells cultured in vitro. We choose Ishikaw a cells as this cell 
line shares characteristics w ith m ature endom etrial epithelial cells [20, 21]. We also 
w anted to  identify a peptide internalized by endom etrial glandular epithelial cells so 
that a dn ig  conjugated with that peptide w ould penetrate target cells. We therefore 
incubated phage with live Ishikaw a cells at 37 °C for 30 m in to facilitate phage inter­
nalization. Selected phage clones were recovered after solubilizing cells w ith deter­
gent and am plified in bacteria. A fter three rounds o f  subtractive library screening, the 
num ber o f  phage clones with Ishikaw a cell- binding activity relative to the total num ­
ber o f  added phage increased 10,000-fold.
The third screen-positive phage pool was overlayed on  frozen tissue sections o f 
endom etriosis lesions surgically isolated from  endom etriosis patients. Im m unohisto- 
chem islry using an anti phage antibody show ed positive signals on glandular epithe­
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lial cells, particularly  at apical cell surfaces in endometriosis. T hese results suggest 
that, despite differences betw een endom etriosis and endom etrial adenocarcinom a, the 
positive phage poo l bound to the Ishikaw a cancer cell line contained a  clone or clones 
binding to  endom etrial glandular epithelial cells. Sequencing o f  insert D N A s from 
isolated phage clones revealed  the deduced consensus sequence V RR A X N X PG  
(w here X represents a varying am ino-acid residue,. The presence o f  the consensus 
sequence attests to  the high specificity o f  selected clones. In vitro b inding assays in ­
dicated that each clone bound to Ishikaw a cells at higher efficiency than to control 
skin ep iderm oid  carcinom a A431 cells. A m ong the clones, z l3 ,  w hich displayed the 
sequence V RRA D N RPG , w as the strongest binder. Z13 phage bound to endom etrial 
adenocarcinom a SNG--II. RL95-2 and H e c lA  cells but not to 431, prostate cancer 
PC3 or cervical cancer H eL a cell.
To confirm  z l3  peptide-binding activity, w e chemically synthesized z l3  peptide 
w ith  an am m o-term inal lluorcscein isothiocyanate (FITC) tag and added to Ishikawa 
cells and contro l A431 cells . F luorescence micrographs showed binding o f  F IT C -zl3  
to Ishikaw a cells , but not to A431 cells. M icrograph o f Ishikawa cells show ed a punc­
tate cytoplasm ic staining patteni, suggesting that z l3  is internalized to endosom es.
F luorescence m icrographs o f  Ishikaw a cells (left) and control A431 cells (nght) 
overlayed w ith a synthetic z.13 peptide tagged with fluorescein isothiocyanate (FITC) 
and left at 37 °C for 15 min. Scale bar, 50 pm. V isualization and isolation o f  the z l3  
peptide receptor. Left: cell surface proteins expressed on Ishikaw a cells w ere bio ti­
nylated. Cell lysates were bound to z 13 peptide- conjugated agarose beads, and bound 
proteins w ere elu ted  with irrelevant peptide (lane 1) or z l3  peptide (lane 2). B io tiny l­
ated proteins in each eluate w ere detected by peroxidase- conjugated avidin and  a lu ­
m inescent peroxidase substrate. Right: silver staining o f  peptide affinity pu rified  z l3  
receptor from  endom etriosis. Endom etriosis tissues isolated from  patients w ere ho ­
m ogenized, and m icrosom e m em brane fraction was prepared. Proteins solubilized 
w ith detergent were applied to  a z l3  peptide conjugated agarose colum n, and bound 
proteins w ere eluted w ith irrelevant peptide (lane 1) or zl.3 peptide (lane 2). P roteins 
in  each eluate in  SD S-PA G E  w ere detected by silver staining, (c) Fluorescence m i­
crographs o f  H eL a cells transfected w ith control empty vector (upper row) or w ith an 
expression  vector encoding CN G B3 M Y C  (lower row). B inding o f  FlTC-z.13 pep­
tide (green) to  HeLa cells transfected w ith  m ammalian expression vectors (a,d), im - 
m unostained w ith anti-M YC follow ed by Alexa 549 (red)-conjugated anti-m ouse IgG 
antibody (b,e) and  m erged im ages including 4',6-diam idino-2 phenylindole (blue) to 
indicate nuclear staining (c.f). Scale bar, 20 urn.
Identification  o f  the zl.3 peptide receptor,
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To develop a clinically relevant therapeutic strategy, w e searched for the /1 3  
peptide receptor. To do so, Ishikawa cells w ere surface biotinylated and lysed, and 
then lysates w ere incubated w ith z 13 peptide-conjugated agarose beads. Bead bound 
m aterials w ere then  eluted by z l3  peptide, and biotinylated proteins detected by avi- 
din blot, revealing a single 68-kDa protein. To identify this protein, the m icrosom al 
m em brane fraction w as prepared from endom etriosis tissue surgically rem oved from 
patients. M em brane proteins solubilized w ith detergent w ere applied to  a z l  3 peptide 
affinity colum n and colum n-bound m aterials were eluted by z l3  peptide. A  silver- 
stained gel revealed a 68-kD a protein, and proleom ic analysis identified the peptide 
sequence, Q RTA LY K , which is unique to the CNGB3 GNGB3 protein has six trans­
m em brane dom ain [22]. A  large part o f  this protein is buncd  in the lipid bilayer, the 
N  and C -term inal dom ains are cytoplasmic and presum ably the z l3 -b ind ing  regions 
are extracellular. To assess binding o f  F IT C -zl3  to  CN G B3, we transfected H eL a 
cells w ith  a m am m alian expression vector encoding a GNGB3—M Y C  fusion protein 
or w ith control em pty vector. FITG-z.13 did no t b ind to  vector transfected control 
cells. H eLa cells transfected w ith the CNGB3--MYG expression construct and stained 
by anti-M YC antibody show ed an endosom e-like pattern . W hen F IT C -zl3  was add­
ed to culture m edium  o f  CNGB3 -M Y C-expressing H eL a cells, F IT C -zl3  bound to 
sites m arked by M Y C epitope expression. The kinetics o f  F IT C -zl3  binding to 
CNGB3 M Y C  expressing HEK293T cells show ed a A'd o f  9.759 x 10 11M  and aB- 
max-of 0,9086 moles per receptor. These results indicate that recom binant CNGB3 ex ­
pressed in  a m am m alian cell has z l 3 peptide-binding activity on the cell surface and 
internalized to  endosom e, supporting the hypothesis that GNGB3 is the z l3  recep- 
tor.To exam ine CNGB3 protein expression in  endom etriosis, w e generated a m ouse 
m onoclonal antibody against a peptide sequence o f  hum an CN G B 3, corresponding to 
K  [12, 14, 151 to P  [1, 3] w ithin the cytoplasm ic domain. A ntibody specificity was 
validated by im m unostaining o f  CNGB3—MYG expressed in H eL a cells. This anti­
body robustly stained glandular epithclia o f  endom etriosis in tissue sections. W hen 
we evaluated  endom etriosis tissue sections from  35 endom etriosis patients, we found 
that 31 specim ens showed strongly positive im m unostaining and 4 show ed 
w eak/negative im m unostaining. Peritoneal surfaces from  cycling w om en w ithout en ­
dom etriosis w ere no t stained by this antibody, w hereas those from  endom etriosis p a ­
tients w ere stained by this antibody, suggesting that endom etrial cells are spread 
across a w ide area on  the peritoneum  o f  endom etriosis patients. Eutopic endom etrial 
tissues a t secretory and proliferative phases w ere w eakly stained by this antibody. 
Im m unohistochem istry o f  hum an tissues show ed that this antibody did not stain the 
surface o f organs facing the peritoneal cavity (data not shown).
Histology o f  hem atoxylin and eosin-stained tissue sections revealed evidence o f  
endom etriosis in  all three anim als treated w ith  a m ixture o f  dKLAK- /1 3  and 1ILA11 
z l3  peptides. Term inal deoxynucleotidyl transferase m ediated dUTP nick end label­
ing (TUNEL) assays o f  endom etriosis lesions collected from  three untreated control 
baboons revealed no TUNEL positivity in gland tissue. By contrast, w e found 
TUNEL positive glands in  tissues collected from  all three baboons treated with the 
dKLAK z l 3 and HLAlT z l 3 peptide mixture, those signals were seen in glandular 
epithelial cells in ovarian endom etriosis and  in the lum en o f  endom etrial gland in  the 
omentum. N o evidence o f  apoptosis w as detected in cells facing peritoneum  in liver, 
kidney, spleen, colon and stom ach (data not shown) These results show  overall, as 
p roo f o f  concept, that /13  targeted induced apoptosis occurred in endom etriosis m od­
el in baboons in vivo.
A  general strategy o f  translational research is to  identity a gene product associ­
ated w ith a disease o f  interest and then develop drug targeting that molecule. H ow ev­
er, in identifying peptides that target endom etriosis but not non endom etrial cells lac ­
ing the peritoneal cavity, w e took a novel approach that does not require know ledge 
o f  a target We also dem onstrated that CNGB3 is the receptor for z l3  peptide based 
on its expression pattern, not its function. We feel that analysing CNG B3 function in 
detail is not a priority' for clinical application o f this work.
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